117 related articles for article (PubMed ID: 37132387)
1. Impact of Palliative Interventions on Survival of Patients with Unresected Pancreatic Cancer: Review of the 2010-2016 National Cancer Database.
Aitken GL; Motta M; Samuels S; Reynolds PT; Gannon CJ; Llaguna OH
Am J Hosp Palliat Care; 2023 Dec; 40(12):1357-1364. PubMed ID: 37132387
[TBL] [Abstract][Full Text] [Related]
2. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
[TBL] [Abstract][Full Text] [Related]
3. Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database.
Hammad AY; Robbins JR; Turaga KK; Christians KK; Gamblin TC; Johnston FM
Ann Palliat Med; 2017 Jan; 6(1):26-35. PubMed ID: 28061532
[TBL] [Abstract][Full Text] [Related]
4. Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer.
Ma SJ; Prezzano KM; Hermann GM; Singh AK
Radiat Oncol; 2018 Nov; 13(1):214. PubMed ID: 30400962
[TBL] [Abstract][Full Text] [Related]
5. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
[TBL] [Abstract][Full Text] [Related]
6. Impact of palliative treatment on survival in sinonasal malignancies.
Farber NI; Povolotskiy R; Bavier RD; Riccardi J; Eloy JA; Hsueh WD
Int Forum Allergy Rhinol; 2019 Dec; 9(12):1499-1507. PubMed ID: 31539454
[TBL] [Abstract][Full Text] [Related]
7. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
[TBL] [Abstract][Full Text] [Related]
8. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
Cheng SH; Cheng YJ; Jin ZY; Xue HD
Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
[TBL] [Abstract][Full Text] [Related]
9. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
[TBL] [Abstract][Full Text] [Related]
10. Association of time interval between cancer diagnosis and initiation of palliative chemotherapy with overall survival in patients with unresectable pancreatic cancer.
Lee SH; Chang PH; Chen PT; Lu CH; Hung YS; Tsang NM; Hung CY; Chen JS; Hsu HC; Chen YY; Chou WC
Cancer Med; 2019 Jul; 8(7):3471-3478. PubMed ID: 31099160
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
12. Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis.
Chambers LM; Jia X; Rose PG; AlHilli M
Gynecol Oncol; 2021 Feb; 160(2):405-412. PubMed ID: 33221023
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808
[TBL] [Abstract][Full Text] [Related]
14. Conversion therapy, palliative chemotherapy and surgery, which of these is the best treatment for locally advanced and advanced pancreatic cancer?
Wang M; Zhu P; Chen Z; Yang L
Anticancer Drugs; 2022 Jan; 33(1):e686-e691. PubMed ID: 34459461
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
Hamad A; Underhill J; Ansari A; Thayaparan V; Cloyd JM; Li Y; Pawlik TM; Tsung A; Abushahin L; Ejaz A
Surgery; 2022 Jun; 171(6):1464-1470. PubMed ID: 35115154
[TBL] [Abstract][Full Text] [Related]
16. The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database.
Amin S; Baine M; Meza J; Alam M; Lin C
Radiat Oncol; 2020 Jun; 15(1):139. PubMed ID: 32493354
[TBL] [Abstract][Full Text] [Related]
17. Palliative gastrectomy for metastatic gastric adenocarcinoma: A national population-based cohort study.
Kamarajah SK; Markar SR; Phillips AW; Salti GI; Dahdaleh F; Griffiths EA
Surgery; 2021 Dec; 170(6):1702-1710. PubMed ID: 34389165
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors in patients with pancreatic squamous cell carcinoma.
Tella SH; Kommalapati A; Yadav S; Bergquist JR; Truty MJ; Durgin L; Ma WW; Cleary SP; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Sep; 45(9):1700-1705. PubMed ID: 31118133
[TBL] [Abstract][Full Text] [Related]
19. Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study.
de Geus SWL; Kasumova GG; Eskander MF; Ng SC; Kent TS; James Moser A; Vahrmeijer AL; Callery MP; Tseng JF
J Gastrointest Surg; 2018 Feb; 22(2):214-225. PubMed ID: 29235000
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma: A single-center retrospective analysis.
Schlick K; Gantschnigg A; Seymer A; Huemer F; Greil R; Weiss L
Cancer Med; 2023 Aug; 12(16):16997-17004. PubMed ID: 37537780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]